OtherClinical Investigations
Prospective Evaluation of the Clinical Value of Planar Bone Scans, SPECT, and 18F-Labeled NaF PET in Newly Diagnosed Lung Cancer
Holger Schirrmeister, Gerhard Glatting, Jürgen Hetzel, Karin Nüssle, Coskun Arslandemir, Andreas K. Buck, Kerstin Dziuk, Andreas Gabelmann, Sven N. Reske and Martin Hetzel
Journal of Nuclear Medicine December 2001, 42 (12) 1800-1804;
Holger Schirrmeister
Gerhard Glatting
Jürgen Hetzel
Karin Nüssle
Coskun Arslandemir
Andreas K. Buck
Kerstin Dziuk
Andreas Gabelmann
Sven N. Reske
FIGURE 2.
FIGURE 2.
Same patient as shown in Figure 1. 18F PET (left, maximum intensity projection images; middle, sagittal; right, coronal) presented BM in vertebral bodies L3 and T10. Both BM were confirmed by MRI.
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Prospective Evaluation of the Clinical Value of Planar Bone Scans, SPECT, and 18F-Labeled NaF PET in Newly Diagnosed Lung Cancer
Holger Schirrmeister, Gerhard Glatting, Jürgen Hetzel, Karin Nüssle, Coskun Arslandemir, Andreas K. Buck, Kerstin Dziuk, Andreas Gabelmann, Sven N. Reske, Martin Hetzel
Journal of Nuclear Medicine Dec 2001, 42 (12) 1800-1804;
Prospective Evaluation of the Clinical Value of Planar Bone Scans, SPECT, and 18F-Labeled NaF PET in Newly Diagnosed Lung Cancer
Holger Schirrmeister, Gerhard Glatting, Jürgen Hetzel, Karin Nüssle, Coskun Arslandemir, Andreas K. Buck, Kerstin Dziuk, Andreas Gabelmann, Sven N. Reske, Martin Hetzel
Journal of Nuclear Medicine Dec 2001, 42 (12) 1800-1804;
Related Articles
- No related articles found.
Cited By...
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
- PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications
- PET/CT with Sodium 18F-Fluoride for Management of Patients with Prostate Cancer
- Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study
- Unmet Needs in the Prediction and Detection of Metastases in Prostate Cancer
- The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology
- SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
- The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
- Magnetic Resonance Imaging Versus Bone Scan in High-Risk Prostatic Carcinoma: Some Methodological Considerations
- Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
- The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
- Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities
- Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
- American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
- PET Imaging of Osteosarcoma
- Molecular Imaging of Protein-Protein Interactions: Controlled Expression of p53 and Large T-Antigen Fusion Proteins in Vivo